COSA's 45th Annual Scientific Meeting, 13 - 15 November 2018 Perth Convention and Exhibition Centre

Breakfast Sessions

Tuesday 13th November

Looking for money? Try improvement and implementation science

Time: 07:00 - 08:15am
Date: Tuesday 13th November 2018
Description: Improvement and implementation sciences are increasingly recognised as critical to ensuring quality of cancer care and timely adoption of best evidence into clinical practice. Research funding bodies require that research proposals consider how research findings will be translated into practice making knowledge of improvement and implementation necessary for both research and practice. This session will outline fundamental concepts of improvement science and implementation science and explore how they can be utilised in clinical practice to improve outcomes and increase value and how they can strengthen research applications to make them more competitive.

Chair: Bogda Koczwara
Speakers: Bogda Koczwara, Nicole Rankin 

This breakfast session is supported by COSA 
COSA Logo BLUE RGB 72dpi

How to manage challenging family interactions and promote effective family involvement in cancer care: Launching the TRIO Guidelines

Time: 07:00 - 08:15am
Date: Tuesday 13th November 2018
Description: Family caregivers regularly attend consultations as patients’ supporters / advocates and often provide unpaid, personalised care to cancer patients. When informed and empowered, family caregivers can be valuable partners in cancer care. However, research shows that oncology clinicians do not always meaningfully engage with family caregivers. Also, some family members can introduce challenges, such as if they dominate the patient, request private patient information, disagree with the patient’s treatment wishes, or display anger towards staff. Building a positive working relationship with family caregivers and managing these challenges requires confidence and skill.

The TRIO Guidelines for communicating with family caregivers provide clear, specific, and evidence-based recommendations for oncology health professionals interacting with a patient’s family.

This session will provide an overview of the TRIO Guidelines, and will highlight specific behaviours and phrases clinicians can use to build a productive relationship with their patients’ family caregivers.

Professionally produced short films will be featured, which demonstrate skills from the TRIO Guidelines used in common clinical scenarios. Attendees will be provided with a hardcopy booklet of the TRIO Guidelines.

Oncology health professionals, researchers, and consumers are invited to attend the TRIO Guidelines breakfast launch.

Chair: Christobel Saunders
Speakers: Ilona Juraskova, Phyllis Butow, Rebekah Laidsaar-Powell 

This breakfast session is supported by COSA 
COSA Logo BLUE RGB 72dpi

 

2018 update on CINV (Chemotherapy Induced Nausea & Vomiting) and TARGIN® tablets – Utilisation in the treatment of chronic cancer pain. 

Time: 07:00 - 08:15am 
Date: Tuesday 13th November 2018 
Description: To discuss the latest antiemetic guideline recommendations and treatment options in chemotherapy induced nausea and vomiting (CINV). This will include the use of NK-1 receptor antagonists or “triple therapy” in patients receiving carboplatin or oxaliplatin – containing chemotherapy agents, emerging evidence in dexamethasone-sparing antiemetic regimens, and data on the NEPA combination as well as olanzapine in CINV control and prevention. This session with explore the data to support the use of TARGIN® tablets in the treatment of chronic cancer pain in daily doses up to 160/80 mg, examine the importance of the ongoing assessment of hepatic function and outline how to manage safe opioid rotation from TARGIN® tablets in light of deteriorating liver function.

This breakfast session is supported by Mundipharma Australia

Mundipharma logo

 

Wednesday 14th November

Meet the Professors, featuring Prof Dirk Arnold & John Edwards

Time: 7:00am – 8:45am
Date: Wednesday 14 November 2018
Description: More information coming soon!

This breakfast session is supported by COSA

COSA Logo BLUE RGB 72dpi

Cancer malnutrition is everyone’s problem – the multidisciplinary approach

Time: 7:00am – 8:45am
Date: Wednesday 14 November 2018
Chair: Nicole Kiss
Speakers: Marian de van der Schueren, other speakers TBA

Description: Join us for this informative and interactive breakfast session where we will discuss the role of members in the multidisciplinary team in the management of malnutrition for cancer patients. This session is open to all members of the MDT. More information coming soon!

This breakfast session is supported by COSA

COSA Logo BLUE RGB 72dpi

N.E.T Connecting the Last 110 Years

Time: 7:00am – 8:45am 
Date: Wednesday 14 November 2018 
Chair: TBC

Description: It is with great pleasure that we invite you all to this year’s Ipsen sponsored symposium – “N.E.T – Connecting the Last 110 Years” – from when Siegfried Orberndorfer first coined the term ‘karzinoide’ for what we now refer to as neuroendocrine tumours (NETs). This screening will take you back in time to 1907, on a journey through the last 110 years of NETs history, focusing on scientific discoveries, diagnostic advances and treatment developments, all of which have contributed to optimising patient care. At pivotal points of the film, our expert faculty will offer insight and opinion on the innovations and collaborations that have led to improvements in patient care over the past century. 

Join us and take your seats to enjoy learning about how the past can help to shape the future.

This breakfast session is supported by Ipsen

Ipsen logo

Mesothelioma and the 3rd wave of exposure

Time: 7:00am - 8:45am
Date: Wednesday 14 November 2018
Chair: TBC
Speaker: Jonathan Walsh, Principal Lawyer, Maurice Blackburn

Description: In 2018, we are seeing still seeing patients diagnosed with mesothelioma. In fact, the numbers continue to remain steady. Asbestos was taken out of building products in 1983 and banned from most work sites in the late 70"s. If we've been efficient in eradicating asbestos, then why are we still experiencing disease. We still have end user exposures, asbestos in buildings and products imported containing asbestos. Exposure continues to occur today. The purpose of this presentation is to discuss the legal ramifications of 3rd wave or in-situte exposures. We will be addressing the complex legal causation issues that such cases throw up together with imported products.

This breakfast session is supported by Maurice Blackburn 

maurice blackburn squarelogo 1447824433414

Thursday 15th November

Best of the Best Poster session A

Time: 7:00am – 8:45am
Date: Thursday 15 November 2018 Topic TBA

This breakfast session is supported by COSA
COSA Logo BLUE RGB 72dpi

Best of the Best Poster session B

Time: 7:00am – 8:45am
Date: Thursday 15 November 2018 Topic TBA

This breakfast session is supported by COSA
COSA Logo BLUE RGB 72dpi